ABT Abbott Laboratories
Stable Earnings Power
B- 64.7 / 100 composite

AlphaQuality composite grade, weighted for stable earnings power businesses.

Profitability

Weight: 20%
C- 46
  • 5yr Avg ROIC 9.4%
  • Operating Margin Trend -0.93 pp/yr

Capital Efficiency

Weight: 15%
B+ 78
  • 5yr Avg ROE 15.2%
  • 5yr Share-Count CAGR -0.6%

Growth Quality

Weight: 15%
D 34
  • 5yr Revenue CAGR 0.7%
  • 5yr EPS CAGR -1.4%
  • Revenue-Growth Years (5) 4/5

Cash Generation

Weight: 15%
A 90
  • 5yr FCF Margin 16.5%
  • 5yr FCF/NI Conversion 0.97x

Balance Sheet

Weight: 20%
A 90
  • Net Debt / EBITDA 0.53x
  • Interest Coverage (EBIT/Int) 25.83x
  • Altman Z-Score 2.96

Stability

Weight: 15%
C- 47
  • EPS Volatility (σ/μ) 0.67
  • Piotroski F-Score 6
  • Negative-Revenue Years (5) 1/5

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Holding

5 of 5 gurus held; 1 new buy; 2 added; 2 trimmed; 1 full exit.

Holders
5 +1
Avg Δ position
+232.1%
New buys
1
Full exits
1
As of Q1 2026